QR Code

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Hōputu: Artigo
Reo:Inglês
I whakaputaina: The Journal of Infection in Developing Countries 2024-05-01
Rangatū:Journal of Infection in Developing Countries
Ngā marau:
Chronic HCV infection
hepatocellular carcinoma
liver cirrhosis
direct-acting antiviral agents
Urunga tuihono:https://jidc.org/index.php/journal/article/view/18410
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite